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2.2. Synthesis, HPLC purification and sequencing pardaxin 
peptides 
Pardaxin and two other peptides composed of 26 and 10 
amino acids from the amino-terminal were synthesized by the 
solid-phase method on PAM resins using HOBT active esters 
(prepared fresh before each step) by mixing Boc amino acid, 
DCC and HOBT at a molar atio of 1 : 1 : 1 at 0°C. The coupling 
reaction proceeded for 0.5 h at 0°C followed by two additional 
hours shaking at room temperature [10]. After cleavage from 
the resin using liquid hydrofluoric acid and preliminary extrac- 
tion, the respective synthetic peptides were purified to a very 
high degree of homogeneity (96-99%) by reverse-phase HPLC 
on either an analytical or semipreparative ultropac, /z- 
Bondapak C18 column (Millipore Corp., Bedford, MA) or 
Vydac protein C4 column (The Separation Group, Hesperia, 
CA). The flow rate was 0.9 ml/min or 3 ml/min, respectively, 
and detection was by absorbance at 210 nm. Amino acid 
analyses of the synthetic peptides were performed using a 
Beckman model 6300 amino acid analyzer with ninhydrin detec- 
tion. The reverse-phase HPLC analyses and separations were 
performed on a Gilson HPLC system composed of a model 811 
dynamic mixer, model 802B manometric module, two model 
303 pumps, and model 116 variable wavelength absorbance 
detector and a NEC model PC-8023A-C recorder, all driven by 
an Apple IIC computer. 
Pardaxin I and II obtained from chromatofocusing [4]and 
the synthetic product were sequenced on an Applied Biosystems 
440A sequencer and the PTH-amino acids analyzed on an Ap- 
plied Biosystems 120A chromatography unit [11]. 
2.3. Lipid bilayer experiments 
Bilayers of PE were formed at the tip of micropipettes bythe 
double-dip method [12]. The solutions in the micropipettes and 
bath (100 mM KC1) were connected by silver/silver chloride 
electrodes to the input of a List EPC7 amplifier in the voltage- 
clamp mode. The clamp potential and the current were recorded 
on a Gould chart recorder. 
2.4. Electrophysiological procedures 
All experiments were performed on the sartorius nerve- 
muscle preparation from frog (Rana temporaria) with normal 
frog Ringer's olution containing (mM): 116 NaC1; 2 KC1; 1.8 
CaCI2; 2-N-hydroxylpiperazine-N'-2-ethanesulfonic acid (pH 
7.2) as previously described [6]. 
3. RESULTS 
3.1. Pardaxin sequence and secondary structure 
predictions 
Pardaxin was sequenced and found to be com- 
posed of  33 common amino acids (table 1). A high 
degree of  similarity to the previously identified ten 
residues at the NH2-terminal [4] is evident. 
Arginine, tyrosine, tryptophan, methionine and 
cysteines were absent. Pardaxin was identical to 
the P. pavonicus toxin P2 recently isolated from 
another species of  Pardachirus flatfish [13]. 
A l though the sequence of  the second pardaxin 
pore forming polypeptide [4] was identical to that 
o f  pardaxin (table 1), these two polypeptides show 
physico-chemical differences [4] that may reflect 
an aggregation process during purification. 
The sequence of  pardaxin was analyzed by the 
program of  Garnier et al. [14] to predict its possi- 
ble secondary structure. The simplest interpreta- 
tion o f  the results (table 1) was a helical region 
extending from residues 1-7 followed by a section 
of  discontinuous extended sheet (residues 8-25).  
The remaining carboxy-terminal region was 
predicted not to have a regular secondary struc- 
ture. Interestingly, the middle port ion of  the 
molecule (residues 6-28) was predicted to have a 
very high amphipathic character (amphipathic 
score 59.1) using the method of  Margalit et al. 
[151. 
The hydrophobic moment  plot o f  pardaxin 
residue values (table 1) based on the consensus 
hydrophobicity scale of  Eisenberg et al. [16] in- 
dicated that most of  the points fell in or near the 
surface region but those for its highly hydrophil ic 
carboxy-terminal lay in the globular region [16]. 
This property is typical for surface-seeking, am- 
phiphilic proteins which have large helical 
hydrophobic moments, such as melittin, 
Staphylococcus aureus ~-toxin and other cytolysins 
[161. 
3.2. Synthesis of pardaxin peptides 
The syntheses o f  pardaxin and the two shorter 
fragments were verified by amino acid analyses 
and sequencing (not shown) and the presence of  
only one major peak on HPLC analyses. The 
native pardaxin isolated by liquid chromatography 
[4] gave two peaks on the C-4 reverse-phase col- 
umn, which eluted at 38 and 56°70 acetonitrile 
(fig. 1A). The sequences of  the materials in the two 
peaks were identical (table 1), suggesting them to 
be physical conformers. 
Surprisingly, synthetic pardaxin gave a single 
peak on HPLC (fig.lB) which was identical to the 
56°70 acetonitrile peak of  the native toxin (fig. 1A). 
To verify a possible chemical interaction between 
the 38 and 56070 peaks, samples of  the native 38o70 
protein peak and the synthetic 56070 peak were mix- 
ed and incubated for 24 h at room temperature. 
The mixture showed two peaks on the C-4 column 
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Table 1 
The amino acid sequence of pardaxin from the flatfish Pardachirus marmoratus and the empirical 
parameters of folding and hydrophobicity 
Residue Amino acid Yield b Secondary structure c Hydrophobicity index Hydrophobic 
number residue a moment f 
A d B e 
I-NH2 Gly 1593 H 3.54 - 1.51 0.18 
2 Phe 362 H 4.71 - 1.51 0.18 
3 Phe 312 H 6.00 - 0.60 0.29 
4 Ala 409 H 6.41 -0.48 0.38 
5 Leu 292 E 5.91 - 0.70 0.45 
6 Ile 267 E 6.17 -0.35 0.47 
7 Pro 266 T 6.42 1.98 0.50 
8 Lys 216 T 6.04 1.98 0.43 
9 Ile 201 T 5.38 - 0.80 0.40 
10 Ile 242 E 4.51 -0.91 0.34 
l l  Set 113 E 5.38 -0.11 0.42 
12 Ser 120 C 6.32 - 0.23 0.33 
13 Pro 74 E 5.12 -0.58 0.37 
14 Leu 41 T 4.38 - 0.88 0.23 
15 Phe 67 E 5.04 -0.53 0.37 
16 Lys 21 E 5.70 -0.20 0.37 
17 Thr 18 E 5.80 -0.95 0.47 
18 Leu 73 E 5.41 -0.88 0.44 
19 Leu 96 E 5.62 - 0.53 0.46 
20 Ser 46 C 6.12 -0.31 0.46 
21 Ala 55 H 6.10 -0.66 0.43 
22 Val 34 E 5.82 - 0.53 0.36 
23 Gly 39 E 5.82 - 0.23 0.37 
24 Set 21 E 5.82 -0.18 0.29 
25 Ala 16 E 5.44 - 0.23 0.24 
26 Leu 20 C 4.71 -0.15 0.18 
27 Ser - C 4.71 0.18 0.26 
28 Ser - C 4.78 0.63 0.17 
29 Ser 33 C 4.02 0.58 0.13 
30 Gly 11 C 3.00 0.53 0.12 
31 Gly 11 C 2.48 0.53 0.17 
32 Gly 8 C 1.97 0.53 0.15 
33-COOH Glu 3 C 1.45 0.50 0.17 
a The line between residues 6 and 28 represents the amphipathic segment of pardaxin determined by 
the method of Margalit et al. [15] which also predicted an amphipathic s ore of 59.1 and a range 
of angles between 80 and 100 ° in the segment with 23 predicted blocks 
b Yields (pmol) of the PTH-amino acid from each cycle of the Edman degradation 
c Computerized secondary structure predictions based on the method of Garnier et al. [14]. H, helix; 
T, ~t-turn; C, coil; E, extended 
d Hydrophobicity values calculated with a computerized program based on the method of Kyte and 
Doolittle [21]. Pardaxin average molecule hydrophobicity is 4.88 
e Hydrophobicity values calculated with a computerized program based on the method of Hopp and 
Woods [22]. Pardaxin average molecule hydrophobicity is -0.31 
f The hydrophobic moment was calculated as described by Eisenberg [10] 
(f ig. 1C) wh ich  suggested that  the  56°7o peak  o f  the 
nat ive  tox in  cannot  be exp la ined  on ly  by an ag- 
g regat ion  process .  Th is  is also suppor ted  by the 
res is tance o f  the  56°70 peak  to  chaot rop ic  agents  
(not  shown) .  The  anomalous  behav iour  o f  the 
nat ive  pardax in  on  the  HPLC-C-4  or  C-18 [4] col-  
umns  cou ld  be a t t r ibuted  e i ther  to the  remova l  o f  
the  aminog lycostero ids  dur ing  the pur i f i ca t ion  
process  [4] or  to an  i r revers ib le  o l igomer iza t ion  
process  wh ich  requires  fu r ther  character i za t ion .  
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Fig. 1. HPLC profiles of native and synthetic pardaxins on a 
reverse-phase C-4 column. (A) Native pardaxin after 
chromatofocusing; (B) synthetic pardaxin after HF cleavage; 
(C) mixture of native and synthetic pardaxin. Column: Vydac 
protein C-4 4.6/250 ram; elution conditions: solvent A, 0.1070 
TFA in water; solvent B, 0.1°70 TFA in acetonitrile. Linear 
gradient from 1507o B to 80070 B in 50 rain. Absorbance at 
210 nm. 
3.3. Effects of synthetic pardaxin on electrical 
properties of planar lipid bilayers 
After the bilayer was found to be stable, pardax- 
in was added to one side, and the potential set at 
20 mV. The currents across the bilayer in the 
voltage-clamp mode usually showed single-channel 
events within 10-20 min (fig.2). The channels pro- 
duced by the synthetic pardaxin were found to be 
similar to those produced by the native one (fig.2). 
However, the synthetic ompound was more po- 
tent. The estimated minimum concentration of 
synthetic pardaxin required to produce channels 
(25 ng/ml) was about one tenth that necessary for 
the natural toxin. A synthetic 26 amino acid frag- 
ment (lacking the 7 amino acids at the carboxy- 
terminal) produced channels but in concentrations 
(100/zg/ml) more than one thousand times that re- 
quired for the 33 residue synthetic peptide. The 
hydrophobic amino-terminal decapeptide had no 
effect up to a concentration of 1.75 mg/ml. 
3.4. The presynaptic effects of synthetic pardaxins 
The presynaptic effects of the synthetic pardaxin 
at the neuromuscular junction were the same as 
those of the native toxin [6] (fig.3); it increased the 
frequency of the spontaneous release of transmit- 
ter quanta as well as the quantal content of the 
evoked end plate potentials (not given) and pro- 
duced a progressive loss of resting potential (fig.3). 
In contrast he pardaxin-derived 26 and 10 pep- 
tides were without effect (lower part of fig.3; note 
that the addition of lanthanum ions (1 mM) caused 
a high-frequency burst of MEPPs before the fre- 
quency fell to zero). 
4. DISCUSSION 
In this report we have shown that the 
chromatographic and biological properties of syn- 
thetic pardaxin are similar or identical to those of 
the natural product isolated from the skin secre- 
tion of P. marmoratus flatfish [4]. The identity of 
the natural and synthetic pardaxin with regard to 
pore and presynaptic activity further suggests that 
the broad spectrum of pharmacological activities 
of native pardaxin [4,7] reflects intrinsic properties 
of this peptide and cannot be attributed to the po- 
tent aminoglycosteroids found in the P. mar- 
moratus ecretion [17]. The synthetic pardaxin was 
found to elute with retention times on HPLC iden- 
tical to one of the peaks of the native peptide sup- 
porting the identity of the peptide sequences of the 
natural and synthetic ompounds. However, the 
presence of two peaks, with identical primary com- 
position, but different in chromatographic 
mobilities which might possibly represent physical 
conformers, requires further investigation. The se- 
quence of pardaxin is unique when compared to 
the common polypeptide channel forming 
ionophores uch as gramicidin [18], alamethicin 
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Fig.2. Single-channel recordings of native (A) and synthetic (B) pardaxin pores. Monolayers of phosphatidylethanolamine w re 
prepared at the air-water interface. Addition of the synthetic or the native pardaxin to the bath resulted, after about 30 rain, in pore 
formation as measured by the current fluctuations represented in A at 100 mV and B at 80 mV positive potentials. The single-channel 
conductance stimated from the amplitudes of the current steps divided by the applied voltage were in the range of 10 pS. 
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Fig.3. The effects of synthetic pardaxin and derived shorter segments on the release of acetylcholine at a single end-plate in the sartorius 
muscle of frog. The muscle was equilibrated in low-calcium Ringer's solution at room temperature. At time zero, the synthetic pardaxin 
(2/zg/ml) or derived peptides were added to the bath. The abscissa in all the graphs represents time in min. Ordinates: (left) the 
frequency of the MEPPs in Hz; (right) the resting potential (RP) in mV. Syn.PX, synthetic pardaxin; PX26, synthetic pardaxin 
fragment of 26 residues from the amino terminal; inset, consecutive additions of micromolar concentrations of the pardaxin derived 
decapeptide. 
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[19] or melitt in [20]. The pardaxin pept ide can be 
conf igured as an amphiphi l ic  a-hel ix which spans 
a l ipid bi layer [7,9]. Furthermore,  models of  the 
pardax in  pores support  an antiparaUel o l igomer of  
several helical pardax in  monomers  [7]. The 
dramat ic  loss o f  pore activity of  the pardaxin  pep- 
t ide shortened to 26 or 10 residues in length is com- 
pat ib le with a mechanism of  act ion that requires 
the pept ide both to span the l ipid bi layer o f  a mem- 
brane as an a-hel ical  structure and to have a 
hydrophi l ic  carboxy-terminal  [7] supposed to be 
involved in selective ion binding and transfer.  The 
avai labi l ty o f  an active synthetic pardaxin peptide 
should facil itate future biophysical  studies on par-  
daxin pore organizat ion and function. 
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